Lipoprotein (a) and incident coronary heart disease in the community: impact of traditional cardiovascular risk factors - Top-Institutions - MDSpire

Lipoprotein (a) and incident coronary heart disease in the community: impact of traditional cardiovascular risk factors

  • By

  • Natalie Arnold

  • Alina Goßling

  • Benjamin Bay

  • Jessica Weimann

  • Christopher Blaum

  • Fabian J Brunner

  • Marco M Ferrario

  • Paolo Brambilla

  • Giancarlo Cesana

  • Valerio Leoni

  • Luigi Palmieri

  • Chiara Donfrancesco

  • Teresa Padró

  • Jonas Andersson

  • Pekka Jousilahti

  • Francisco Ojeda

  • Tanja Zeller

  • Allan Linneberg

  • Stefan Söderberg

  • Licia Iacoviello

  • Francesco Gianfagna

  • Susana Sans

  • Giovanni Veronesi

  • Barbara Thorand

  • Annette Peters

  • Hugh Tunstall-Pedoe

  • Frank Kee

  • Veikko Salomaa

  • Renate B Schnabel

  • Kari Kuulasmaa

  • Stefan Blankenberg

  • Christoph Waldeyer

  • Wolfgang Koenig

  • on behalf of the BiomarCARE investigators

  • June 12, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, N/A

    Key Differentiators

    • Cardiology
    • Cardiovascular Epidemiology
    • Lipidology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Cardiovascular Epidemiology
    • Preventive Medicine

  • #3

    University of Cambridge
    University of Cambridge

    Cambridge, N/A

    Key Differentiators

    • Cardiology
    • Epidemiology
    • Genetics

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Lipidology
    • Preventive Cardiology

  • #5

    Imperial College London
    Imperial College London

    London, N/A

    Key Differentiators

    • Cardiology
    • Public Health
    • Epidemiology

Original Source(s)

Lipoprotein (a) and incident coronary heart disease in the community: impact of traditional cardiovascular risk factors

  • by Natalie Arnold, Alina Goßling, Benjamin Bay, Jessica Weimann, Christopher Blaum, Fabian J Brunner, Marco M Ferrario, Paolo Brambilla, Giancarlo Cesana, Valerio Leoni, Luigi Palmieri, Chiara Donfrancesco, Teresa Padró, Jonas Andersson, Pekka Jousilahti, Francisco Ojeda, Tanja Zeller, Allan Linneberg, Stefan Söderberg, Licia Iacoviello, Francesco Gianfagna, Susana Sans, Giovanni Veronesi, Barbara Thorand, Annette Peters, Hugh Tunstall-Pedoe, Frank Kee, Veikko Salomaa, Renate B Schnabel, Kari Kuulasmaa, Stefan Blankenberg, Christoph Waldeyer, Wolfgang Koenig, on behalf of the BiomarCARE investigators

  • June 12, 2025

Related Content

Establishment and validation of a machine learning-based predictive model for in-hospital mortality risk in acute myocardial infarction patients complicated with diabetes mellitus

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study